Sansure Immunological Technology Platform adopts advanced nanoparticle technology, protein labelling and modification technology, using high quality coloured latex and colloidal gold as tracers, and has developed a series of easy-to-use, highly sensitive and rapid detection products, covering SARS-CoV-2 antigen, SARS-CoV-2/InFluA/InFluB antigen, SARS-CoV-2 neutralizing antibody and other SARS-CoV-2 immunological reagents, to meet the needs of different scenarios such as home self-test, POCT and laboratory testing.
Antiretroviral therapy (ART) for people living with HIV, despite its success, is not a cure for HIV and patients still need lifelong treatment. HIV integrates into the host genome and persists throughout the life cycle of infected cells. These latently infected cells are not recognized as foreign cells because they are largely transcriptionally silent, but discontinuing ART for viruses that […]
From the beginning of the COVID-19 to the summer of 2021, the global seasonal influenza cases have drastically decreased in comparison with that of previous years thanks to the strict public health and social measures adopted by countries around the world. However, influenza cases increase with the relaxation of epidemic prevention in many countries by the end of 2021. Besides, […]